RxSight (RXST) Enterprise Value (2020 - 2025)
Historic Enterprise Value for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to -$425.4 million.
- RxSight's Enterprise Value rose 702.01% to -$425.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$425.4 million, marking a year-over-year increase of 702.01%. This contributed to the annual value of -$457.7 million for FY2024, which is 8706.0% down from last year.
- According to the latest figures from Q3 2025, RxSight's Enterprise Value is -$425.4 million, which was up 702.01% from -$414.6 million recorded in Q2 2025.
- In the past 5 years, RxSight's Enterprise Value ranged from a high of -$81.7 million in Q2 2021 and a low of -$457.7 million during Q4 2024
- Its 5-year average for Enterprise Value is -$304.7 million, with a median of -$276.9 million in 2021.
- Its Enterprise Value has fluctuated over the past 5 years, first crashed by 61766.41% in 2021, then surged by 3211.43% in 2022.
- Over the past 5 years, RxSight's Enterprise Value (Quarter) stood at -$294.3 million in 2021, then skyrocketed by 32.11% to -$199.8 million in 2022, then fell by 22.49% to -$244.7 million in 2023, then tumbled by 87.06% to -$457.7 million in 2024, then rose by 7.06% to -$425.4 million in 2025.
- Its Enterprise Value stands at -$425.4 million for Q3 2025, versus -$414.6 million for Q2 2025 and -$430.6 million for Q1 2025.